Meridia: Abbott Laboratories Appetite suppressant
Xenical: Hoffmann-La Roche Inc. Blocks the absorption of fat
Acomplia*: Sanofi-Aventis SA Reduces overactivity in the body's system that regulates food intake and energy expenditure
PYY (3-36) Nasal Spray* Nastech Pharmaceutical Company Inc. Binds to receptors in the hypothalamus of the brain to signal satiety
posted by Richard Sprague at 6:54 AM on Oct 5, 2004
"Obesity: the next big drug target"
No comments yet. -